
Autoimmune retinopathy is a cause of unexplained visual impairment and visual field impairment, which are often related with life-threatening cancers. Here, we report a case of autoimmune retinopathy positive for anti-paraneoplastic antigen MA2 (PNMA2) antibody in serum. Visual acuity and field were impaired, and OCT and ERG were performed. No abnormalities were observed in OCT, but a marked decrease in pyramidal response was observed in ERG. Paraneoplastic antigen-related antibodies in the serum were tested, and PNMA2 was positive. Systemic evaluation to search for the presence of cancer was conducted by specialists treating cancer. However, cancers were not detected, but bladder and prostate cancer were identified 3 years later, and anti-PNMA2 antibodies were again positive in the serum. Although there have been no reports on PNMA2-related retinopathy, the possibility of the paraneoplastic syndrome should be kept in mind when retinopathy of unknown cause is observed.
Ophthalmology, cancer, Case Report, autoimmune retinopathy, paraneoplastic antigen ma2, RE1-994
Ophthalmology, cancer, Case Report, autoimmune retinopathy, paraneoplastic antigen ma2, RE1-994
| citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
